Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a common numbing drug ease Post-Brain bleed headaches?

NCT ID NCT06582810

Recruiting now Symptom relief Sponsor: University of Kansas Medical Center Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study looks at whether an intravenous lidocaine infusion can safely reduce moderate to severe headache pain in people recovering from a non-traumatic subarachnoid hemorrhage (a type of brain bleed). Twenty adult participants with favorable neurological status will receive lidocaine and report their pain levels every two hours for up to seven days. The researchers also monitor for vasospasm, a common complication. The goal is to see if lidocaine provides meaningful pain relief and is safe in this setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lidocaine infusion
What this could lead to
If it works, this could offer a new way to manage severe headaches after a brain bleed, potentially reducing reliance on opioids.
What could go wrong
This is a small, early observational study with only 20 participants, so results may not apply widely. Lidocaine can cause side effects like dizziness or heart issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEADACHE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Headache headache disorder Hemorrhage subarachnoid hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEADACHE SUBARACHNOID; HEMORRHAGE, NONTRAUMATIC

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ascension Via Christi St. Francis

    RECRUITING

    Wichita, Kansas, 67214, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.